drugset / Trial / NCT03222427
A Study of LY3314814 in Healthy Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to measure how much LY3314814 gets into the bloodstream when it is given as a single dose by mouth and as an intravenous (IV) infusion over two hours. The study will last at least two weeks for each participant, not including screening.
Timeline
- Start
- 2018-01-15
- Primary completion
- 2018-02-16
- Completion
- 2018-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lanabecestat | Small molecule | 100 ug | Oral |
| Subject | Lanabecestat | Small molecule | 50 mg | Oral |
Indications
No indication recorded.